Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Danipharm A/S is a Danish pharmaceutical manufacturing company and a key subsidiary of the BIOFAC Group, specializing in the production of high-quality Active Pharmaceutical Ingredients (APIs). Founded in 1988 and headquartered in Kastrup, Denmark, the company is globally recognized as a leading supplier of Lactulose in bulk form. Its manufacturing facility in Northern Jutland is fully automated and operates under strict cGMP standards, maintaining approvals from the US FDA and the Danish Health Authorities. Danipharm provides essential ingredients for gastroenterology and hepatology treatments, often working in tandem with its subsidiary PharmaDan A/S to offer filling and packaging for finished liquid dosage forms. The company serves an international market, delivering pharmaceutical-grade disaccharides and related compounds to global healthcare providers.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Danipharm.